PL358304A1 - Peptyd modulujący aktywność receptora trombopoetyny - Google Patents

Peptyd modulujący aktywność receptora trombopoetyny

Info

Publication number
PL358304A1
PL358304A1 PL01358304A PL35830401A PL358304A1 PL 358304 A1 PL358304 A1 PL 358304A1 PL 01358304 A PL01358304 A PL 01358304A PL 35830401 A PL35830401 A PL 35830401A PL 358304 A1 PL358304 A1 PL 358304A1
Authority
PL
Poland
Prior art keywords
receptor modulating
thrombopoietin receptor
modulating peptide
peptide
thrombopoietin
Prior art date
Application number
PL01358304A
Other languages
English (en)
Inventor
Tatjana Naranda
Lennart Olsson
Original Assignee
Pliva, Farmaceutska Industrija, Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva, Farmaceutska Industrija, Dionicko Drustvo filed Critical Pliva, Farmaceutska Industrija, Dionicko Drustvo
Publication of PL358304A1 publication Critical patent/PL358304A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL01358304A 2000-04-25 2001-04-23 Peptyd modulujący aktywność receptora trombopoetyny PL358304A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Publications (1)

Publication Number Publication Date
PL358304A1 true PL358304A1 (pl) 2004-08-09

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01358304A PL358304A1 (pl) 2000-04-25 2001-04-23 Peptyd modulujący aktywność receptora trombopoetyny

Country Status (24)

Country Link
US (1) US20030181659A1 (pl)
EP (2) EP1149906A1 (pl)
JP (1) JP2003530867A (pl)
KR (1) KR20030009450A (pl)
CN (1) CN1426467A (pl)
AR (1) AR030278A1 (pl)
AU (2) AU6736601A (pl)
BG (1) BG107214A (pl)
BR (1) BR0110383A (pl)
CA (1) CA2407167A1 (pl)
CZ (1) CZ20023517A3 (pl)
EA (1) EA006423B1 (pl)
EE (1) EE200200610A (pl)
GE (1) GEP20063763B (pl)
HU (1) HUP0300559A3 (pl)
IL (1) IL152204A0 (pl)
IS (1) IS6582A (pl)
MX (1) MXPA02010458A (pl)
NO (1) NO20025114L (pl)
PL (1) PL358304A1 (pl)
SK (1) SK15262002A3 (pl)
WO (1) WO2001080873A2 (pl)
YU (1) YU79202A (pl)
ZA (1) ZA200208662B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508173A (ja) * 2001-11-07 2005-03-31 ミレニアム・ファーマシューティカルズ・インコーポレイテッド ２３２、２０５９、１０６３０、１２８４８、１３８７５、１４３９５、１４６１８、１７６９２または５８８７４を使用する血液障害を処置するための方法および組成物
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
MXPA05003057A (es) * 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
CN1739017B (zh) 2002-12-11 2011-04-06 弗罗桑医疗设备公司 用作拭子的基于明胶的材料
CA2525399A1 (en) * 2003-05-12 2004-11-25 Affymax, Inc. Novel spacer moiety for poly(ethylene glycol)-modified peptide-based co mpounds
KR20060028675A (ko) * 2003-05-12 2006-03-31 아피맥스, 인크. 신규한 폴리 (에틸렌 글리콜) 개질 화합물 및 그의 용도
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
JP2007519450A (ja) 2004-01-30 2007-07-19 フェロサン アー／エス 止血用のスプレーおよび組成物
AU2005262070B2 (en) 2004-07-09 2011-01-27 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
ES2373989T3 (es) * 2006-01-31 2012-02-10 Mitsubishi Chemical Medience Corporation Procedimiento para la determinación del estado de un síndrome de coagulación intravascular diseminada.
JP5569398B2 (ja) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー／エス 止血および／または創傷治癒を促進するための装置
CN103814126B (zh) * 2011-05-13 2017-10-24 国立大学法人东京大学 多核巨核细胞以及血小板的制造方法
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
CN104349797B (zh) 2012-06-12 2017-10-27 弗罗桑医疗设备公司 干止血组合物
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
WO2015086028A1 (en) 2013-12-11 2015-06-18 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
MX2020011866A (es) 2018-05-09 2021-01-20 Ferrosan Medical Devices As Metodo para preparar una composicion hemostatica.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
YU34196A (sh) * 1995-06-07 1999-03-04 Glaxo Group Limited Peptidi i jedinjenja koja se vezuju za receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
WO1999042127A2 (en) * 1998-02-24 1999-08-26 Receptron, Inc. Receptor derived peptides as modulators of receptor activity

Also Published As

Publication number Publication date
CN1426467A (zh) 2003-06-25
EA006423B1 (ru) 2005-12-29
EA200201138A1 (ru) 2003-06-26
IL152204A0 (en) 2003-05-29
CZ20023517A3 (cs) 2003-10-15
KR20030009450A (ko) 2003-01-29
WO2001080873A3 (en) 2002-01-31
BR0110383A (pt) 2003-01-21
HUP0300559A3 (en) 2005-09-28
AU2001267366B2 (en) 2005-06-30
CA2407167A1 (en) 2001-11-01
NO20025114D0 (no) 2002-10-24
WO2001080873A2 (en) 2001-11-01
IS6582A (is) 2002-10-14
HUP0300559A2 (hu) 2003-06-28
AU6736601A (en) 2001-11-07
EP1278849A2 (en) 2003-01-29
US20030181659A1 (en) 2003-09-25
NO20025114L (no) 2002-12-18
YU79202A (sh) 2006-01-16
AR030278A1 (es) 2003-08-20
JP2003530867A (ja) 2003-10-21
BG107214A (bg) 2003-11-28
MXPA02010458A (es) 2003-06-06
GEP20063763B (en) 2006-03-10
SK15262002A3 (sk) 2003-05-02
EP1149906A1 (en) 2001-10-31
AU2001267366B9 (en) 2005-07-14
ZA200208662B (en) 2003-10-27
EE200200610A (et) 2004-08-16

Similar Documents

Publication Publication Date Title
AU6736601A (en) Thrombopoietin receptor modulating peptide
GB0014870D0 (en) Peptides
GB0029777D0 (en) Peptides
AU6268901A (en) Oligopeptides
GB0015761D0 (en) Polypeptide
GB0000474D0 (en) Receptor
GB0127017D0 (en) New polypeptide
AU1252102A (en) Receptor
GB0001825D0 (en) Peptides
GB0121215D0 (en) Polypeptide
HK1054406A (en) Thrombopoietin receptor modulating peptide
GB0124559D0 (en) New polypeptide
GB0007263D0 (en) Peptides
GB0027537D0 (en) New polypeptide
GB2388486B (en) Projection unit
GB0013239D0 (en) Polypeptide
EP1323731A4 (en) NEW PEPTIDES
GB0012199D0 (en) New polypeptide
GB0027989D0 (en) Modulator
GB0020946D0 (en) Modulator
GB0007264D0 (en) Peptides
GB0001826D0 (en) Peptides
GB0010327D0 (en) Peptides
GB0021475D0 (en) Anti-aniogenic peptides
AU1790P (en) Jabiru Glycine max

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)